The Security and Surveillance division provides

New Post Public Reply Private Reply Replies (0) Message Board
budfoxfun
107
The Security and Surveillance division provides surveillance systems, and digital video recording and services, including DVR recorders and cameras, video intercoms, NVR recorders and IP cameras, laser and video beam perimeter security products, motion detection and thermal imagery products, security design and consulting, remote control device management, equipment maintenance service plans, and access control solutions.

It also develops customized software programs; and DirectView Security App, a mobile application to enable full remote management of deployed surveillance devices, such as positioning cameras, setting recording parameters, and replay of selected video. This division serves transportation, hospitality, industrial, educational, and residential markets. The Video Conferencing Services division provides multipoint video conferencing, network integration, custom room design, staffing, document conferencing, and IP/Web conferencing services that enable its clients to conduct remote meetings by linking participants in geographically dispersed locations. It is also involved in the sale of conferencing services based upon usage, sale and installation of video equipment, and sale of maintenance agreements.

This division provides its services to organizations, such as professional service firms, investment banks, high tech companies, law firms, investor relations firms, and other domestic and multinational companies in commercial, government, medical, and educational sectors. The company sells its products and services in the United States and internationally through direct sales force, referrals, and its Website. DirectView Holdings, Inc. was founded in 2006 and is based in Boca Raton, Florida.

DIRV

DirectView Holdings, Inc. (DIRV) Stock Research Links

DIRV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Advances in AI and Digital R&D Innovation by ICON plc

Updated Category News Views 227

Recent Developments in AI and Digital Innovation by ICON plc ICON plc, a globally recognized clinical research organization (NASDAQ: ICLR), has recently conducted an extensive survey exploring the integration of Artificial Intelligence (AI) and digital tools within clinical research. Engaging with over 100 professionals in the biotech and pharmaceutical industries across...

Continue Reading
Tesla's Self-Driving Claims Under Fire: Industry Reactions

Updated Category News Views 167

Tesla's License Suspension in California Recently, a court in California announced a significant development affecting Tesla Inc. (NASDAQ: TSLA). The court decided to suspend Tesla's license to sell vehicles for 30 days due to a lawsuit concerning misleading claims about the company's Full Self-Driving (FSD) technology. If Tesla does not adapt its policies within 90 days,...

Continue Reading
Sunnova Energy Faces Challenges Amid Revenue Declines in 2024

Updated Category News Views 384

Sunnova Energy Experiences Financial Struggles Sunnova Energy International Inc. (NOVA) has encountered a challenging period, with its shares trading lower in the premarket on Monday following a disappointing report detailing its fourth quarter and full-year financial results. The financial landscape for Sunnova shows a revenue of $224.127 million, which unfortunately...

Continue Reading
Kerusso's Important Contributions in Faith and Community Work

Updated Category News Views 133

Kerusso's Inspiring Charitable Contributions in 2025 Kerusso Activewear, a prominent Christian apparel and gift brand, has ended the year with a remarkable achievement of over $400,000 in charitable contributions. This reflects their steadfast commitment to enriching lives through faith-based approaches and generous support for individuals in need. Growing Demand for...

Continue Reading
Prelude Therapeutics and Incyte Join Forces for JAK2JH2 Inhibitor

Updated Category News Views 101

Prelude Therapeutics Partners with Incyte on JAK2V617F Program Incyte establishes exclusive option to acquire Prelude’s innovative programs These inhibitors have the potential to modify disease outcomes in patients with myeloproliferative neoplasms (MPNs) Prelude Therapeutics, a clinical-stage oncology company, has recently made headlines with an exciting announcement...

Continue Reading